• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国多发性硬化症的临床特征和转归:韩国的多发性硬化症真的与白种人群不同吗?

Clinical characteristics and outcome of multiple sclerosis in Korea: does multiple sclerosis in Korea really differ from that in the Caucasian populations?

机构信息

Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang-si, Korea.

出版信息

Mult Scler. 2013 Oct;19(11):1493-8. doi: 10.1177/1352458513477712. Epub 2013 Feb 13.

DOI:10.1177/1352458513477712
PMID:23407702
Abstract

BACKGROUND

Multiple sclerosis (MS) in Asia is thought to have different clinical characteristics from MS in Western countries; however, previous studies in Asia were performed without properly differentiating neuromyelitis optica (NMO) from MS.

OBJECTIVES

To evaluate the clinical characteristics of MS in Korea after careful exclusion of potential explanations other than MS, particularly NMO spectrum disorder (NMOSD).

METHODS

This study is a retrospective review of consecutive MS patients attending five referral hospitals in Korea. All patients' MS diagnoses were re-evaluated.

RESULTS

Of the 105 patients, 70 were female and 35 were male. The mean age of onset was 30.4 years and the mean disease duration was 5.4 years. On initial magnetic resonance imaging (MRI), 58% and 64% fulfilled the criteria for dissemination in space for the 2005 and 2010 McDonald criteria, respectively. Spinal cord lesions were observed in 78% of patients, primarily present as multiple small lesions with a mean length of 0.9 vertebral segments. The median time from disease onset to an Expanded Disability Status Scale 6 was 20 years.

CONCLUSIONS

After careful exclusion of NMOSD, we found that the clinical pattern of MS in Korea does not fundamentally differ from that seen in Western countries.

摘要

背景

亚洲多发性硬化症(MS)的临床特征与西方国家的 MS 不同;然而,亚洲之前的研究没有将视神经脊髓炎(NMO)与 MS 正确区分开来。

目的

在仔细排除 MS 以外的潜在解释因素,特别是 NMOSD 后,评估韩国 MS 的临床特征。

方法

这是一项对韩国五家转诊医院的连续 MS 患者进行的回顾性研究。对所有患者的 MS 诊断进行重新评估。

结果

105 例患者中,70 例为女性,35 例为男性。发病年龄平均为 30.4 岁,病程平均为 5.4 年。初次磁共振成像(MRI)时,分别有 58%和 64%符合 2005 年和 2010 年 McDonald 标准的空间弥散标准。78%的患者存在脊髓病变,主要表现为多个小病变,平均长度为 0.9 个椎体节段。从发病到扩展残疾状况量表 6 的中位时间为 20 年。

结论

在仔细排除 NMOSD 后,我们发现韩国 MS 的临床模式与西方国家没有根本区别。

相似文献

1
Clinical characteristics and outcome of multiple sclerosis in Korea: does multiple sclerosis in Korea really differ from that in the Caucasian populations?韩国多发性硬化症的临床特征和转归:韩国的多发性硬化症真的与白种人群不同吗?
Mult Scler. 2013 Oct;19(11):1493-8. doi: 10.1177/1352458513477712. Epub 2013 Feb 13.
2
Pediatric-onset multiple sclerosis in Brazilian patients: Clinical features, treatment response and comparison to pediatric neuromyelitis optica spectrum disorders.巴西患儿多发性硬化症:临床特征、治疗反应及与小儿视神经脊髓炎谱系疾病的比较。
Mult Scler Relat Disord. 2018 Oct;25:138-142. doi: 10.1016/j.msard.2018.07.036. Epub 2018 Jul 20.
3
Is Asian type MS an MS phenotype, an NMO spectrum disorder, or a MOG-IgG related disease?亚洲型多发性硬化症是多发性硬化症表型、视神经脊髓炎谱系疾病还是 MOG-IgG 相关疾病?
Mult Scler Relat Disord. 2020 Jul;42:102082. doi: 10.1016/j.msard.2020.102082. Epub 2020 Apr 13.
4
Therapeutic efficacy of interferon β-1b in Japanese patients with optic-spinal multiple sclerosis.干扰素 β-1b 治疗日本视神经脊髓型多发性硬化症患者的疗效。
Tohoku J Exp Med. 2011 Mar;223(3):211-4. doi: 10.1620/tjem.223.211.
5
Association of Optic Neuritis with Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis in Korea.韩国视神经炎与视神经脊髓炎谱系障碍及多发性硬化症的关联
Korean J Ophthalmol. 2019 Feb;33(1):82-90. doi: 10.3341/kjo.2018.0050.
6
Relapsing demyelinating CNS disease in a Korean pediatric population: multiple sclerosis versus neuromyelitis optica.韩国儿科人群中的复发性脱髓鞘中枢神经系统疾病:多发性硬化症与视神经脊髓炎。
Mult Scler. 2011 Jan;17(1):67-73. doi: 10.1177/1352458510382685. Epub 2010 Sep 21.
7
[The correlation factor analysis for conversion of clinically isolated syndrome to multiple sclerosis and neuromyelitis optica].[临床孤立综合征向多发性硬化症和视神经脊髓炎转化的相关因素分析]
Zhonghua Nei Ke Za Zhi. 2016 Jun;55(6):460-5. doi: 10.3760/cma.j.issn.0578-1426.2016.06.012.
8
Characterisation of the spectrum of demyelinating disease in Western Australia.西澳大利亚脱髓鞘疾病谱系的特征描述。
J Neurol Neurosurg Psychiatry. 2008 Sep;79(9):1022-6. doi: 10.1136/jnnp.2007.131177. Epub 2008 Mar 20.
9
[Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].视神经脊髓炎及视神经脊髓炎谱系障碍患儿的临床特征与随访
Zhonghua Er Ke Za Zhi. 2015 Apr;53(4):268-73.
10
The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders.发病时脑部磁共振成像在鉴别多发性硬化和血清学阳性视神经脊髓炎谱系障碍中的作用。
Mult Scler. 2014 May;20(6):695-704. doi: 10.1177/1352458513506953. Epub 2013 Sep 26.

引用本文的文献

1
A comparison of multiple sclerosis disease characteristics across three genetically diverse Asian racial groups in Singapore.在新加坡三个具有不同遗传背景的亚洲种族群体中比较多发性硬化症的疾病特征。
Sci Rep. 2024 Jun 26;14(1):14690. doi: 10.1038/s41598-024-65575-3.
2
Recent progress in epidemiology, clinical features, and therapy of multiple sclerosis in China.中国多发性硬化症在流行病学、临床特征及治疗方面的最新进展
Ther Adv Neurol Disord. 2023 Sep 15;16:17562864231193816. doi: 10.1177/17562864231193816. eCollection 2023.
3
Do magnetic resonance imaging features differ between persons with multiple sclerosis of various races and ethnicities?
不同种族和民族的多发性硬化症患者的磁共振成像特征是否存在差异?
Front Neurol. 2023 Jun 28;14:1215774. doi: 10.3389/fneur.2023.1215774. eCollection 2023.
4
Model-informed assessment of ethnic sensitivity and dosage justification for Asian populations in the global clinical development and use of cladribine tablets.基于模型的 cladribine 片剂在全球临床开发和使用中对亚洲人群的人种敏感性评估和剂量合理性探讨。
Clin Transl Sci. 2022 Feb;15(2):297-308. doi: 10.1111/cts.13166. Epub 2021 Oct 26.
5
Spinal Cord Involvement in MS and Other Demyelinating Diseases.脊髓在多发性硬化症及其他脱髓鞘疾病中的受累情况。
Biomedicines. 2020 May 22;8(5):130. doi: 10.3390/biomedicines8050130.
6
Real-World Effectiveness of Disease-Modifying Therapies in Korean Patients with Relapsing Multiple Sclerosis.疾病修饰疗法对韩国复发型多发性硬化症患者的真实世界有效性
J Clin Neurol. 2019 Jan;15(1):20-26. doi: 10.3988/jcn.2019.15.1.20. Epub 2018 Oct 26.
7
Multiple Sclerosis Patients with Markedly Low Intrathecal Antibody Response in Sri Lanka.斯里兰卡鞘内抗体反应显著低下的多发性硬化症患者。
Mult Scler Int. 2018 Feb 28;2018:5342936. doi: 10.1155/2018/5342936. eCollection 2018.
8
MRI in the assessment and monitoring of multiple sclerosis: an update on best practice.磁共振成像在多发性硬化症评估与监测中的应用:最佳实践的最新进展
Ther Adv Neurol Disord. 2017 Jun;10(6):247-261. doi: 10.1177/1756285617708911. Epub 2017 May 12.
9
Challenges in randomized controlled trials and emerging multiple sclerosis therapeutics.随机对照试验中的挑战与新兴的多发性硬化症治疗方法
Neurosci Bull. 2015 Dec;31(6):745-54. doi: 10.1007/s12264-015-1560-6.
10
Utility of the rio score and modified rio score in korean patients with multiple sclerosis.
PLoS One. 2015 May 26;10(5):e0129243. doi: 10.1371/journal.pone.0129243. eCollection 2015.